63345 Real-World Comorbidities of Adult Patients With Prurigo Nodularis Initiating Dupilumab in the US by Race/Ethnicity
Shawn G. Kwatra(University of Maryland, Baltimore), Kwinten Bosman(Regeneron (United States)), Natalia Petruski‐Ivleva(AVEO Oncology (United States)), Joseph Zahn(Regeneron (United States)), Danielle Sienko, Tiange Yu, Sarah Chisolm(Emory University), Catherine Allende, Danielle L. Isaman(Aetion (United States)), Simmi Wiggins(Sanofi (United Kingdom)), Nicholas Mollanazar(University of Pennsylvania Health System)
Cited by 0
Related Papers
Dietary Protein Sources and Risk for Incident Chronic Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study
|Journal of Renal Nutrition|2017|254
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis
|New England Journal of Medicine|2023|184
Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults
|Annals of the Rheumatic Diseases|2023|95
Depression, Anxiety, and Self-Directed Violence in Women With Endometriosis: A Retrospective Matched-Cohort Study
|American Journal of Epidemiology|2020|66